Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

The prevalence of alpha-1 antitrypsin deficiency among patients found to have airflow obstruction.

Rahaghi FF, Sandhaus RA, Brantly ML, Rouhani F, Campos MA, Strange C, Hogarth DK, Eden E, Stocks JM, Krowka MJ, Stoller JK.

COPD. 2012 Aug;9(4):352-8. doi: 10.3109/15412555.2012.669433. Epub 2012 Apr 16. Erratum in: COPD. 2013 Aug;10(4):555. Brantly, Mark L [added]; Rouhani, Farshid [added]; Campos, Michael A [added].

PMID:
22506682
2.

Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?

Beletic A, Dudvarski-Ilic A, Milenkovic B, Nagorni-Obradovic L, Ljujic M, Djordjevic V, Mirkovic D, Radojkovic D, Majkic-Singh N.

Biochem Med (Zagreb). 2014;24(2):293-8. doi: 10.11613/BM.2014.032. Epub 2014 Jun 15.

4.

Physician alert suggesting alpha-1 antitrypsin deficiency testing in pulmonary function test (PFT) results.

Rahaghi F, Ortega I, Rahaghi N, Oliveira E, Ramirez J, Smolley L, Stoller JK.

COPD. 2009 Feb;6(1):26-30. doi: 10.1080/15412550802587927.

PMID:
19229705
5.

Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.

Demeo DL, Sandhaus RA, Barker AF, Brantly ML, Eden E, McElvaney NG, Rennard S, Burchard E, Stocks JM, Stoller JK, Strange C, Turino GM, Campbell EJ, Silverman EK.

Thorax. 2007 Sep;62(9):806-13. Epub 2007 Mar 27.

6.

Screening for alpha1-antitrypsin deficiency in Lithuanian patients with COPD.

Sitkauskiene B, Serapinas D, Blanco I, Fernández-Bustillo E, Janciauskiene S, Sakalauskas R.

Respir Med. 2008 Nov;102(11):1654-8. doi: 10.1016/j.rmed.2008.07.003. Epub 2008 Aug 21.

7.

Clarification of the risk of chronic obstructive pulmonary disease in α1-antitrypsin deficiency PiMZ heterozygotes.

Molloy K, Hersh CP, Morris VB, Carroll TP, O'Connor CA, Lasky-Su JA, Greene CM, O'Neill SJ, Silverman EK, McElvaney NG.

Am J Respir Crit Care Med. 2014 Feb 15;189(4):419-27. doi: 10.1164/rccm.201311-1984OC.

PMID:
24428606
8.

Indications for active case searches and intravenous alpha-1 antitrypsin treatment for patients with alpha-1 antitrypsin deficiency chronic pulmonary obstructive disease: an update.

Casas F, Blanco I, Martínez MT, Bustamante A, Miravitlles M, Cadenas S, Hernández JM, Lázaro L, Rodríguez E, Rodríguez-Frías F, Torres M, Lara B.

Arch Bronconeumol. 2015 Apr;51(4):185-92. doi: 10.1016/j.arbres.2014.05.008. Epub 2014 Jul 12. English, Spanish.

9.

IL10 polymorphisms are associated with airflow obstruction in severe alpha1-antitrypsin deficiency.

Demeo DL, Campbell EJ, Barker AF, Brantly ML, Eden E, McElvaney NG, Rennard SI, Sandhaus RA, Stocks JM, Stoller JK, Strange C, Turino G, Silverman EK.

Am J Respir Cell Mol Biol. 2008 Jan;38(1):114-20. Epub 2007 Aug 9.

10.

Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values.

Pérez-Rubio G, Jiménez-Valverde LO, Ramírez-Venegas A, Camarena Á, Sansores RH, Flores-Trujillo F, Reséndiz-Hernández JM, Falfán-Valencia R.

Arch Bronconeumol. 2015 Feb;51(2):80-5. doi: 10.1016/j.arbres.2014.09.010. Epub 2014 Nov 7. English, Spanish.

11.

Hereditary alpha-1-antitrypsin deficiency and its clinical consequences.

Fregonese L, Stolk J.

Orphanet J Rare Dis. 2008 Jun 19;3:16. doi: 10.1186/1750-1172-3-16. Review.

12.

A review of alpha-1 antitrypsin deficiency.

Ranes J, Stoller JK.

Semin Respir Crit Care Med. 2005 Apr;26(2):154-66. Review.

PMID:
16088434
13.

Prevalence of α-1-antitrypsin gene mutations in Saudi Arabia.

Aljarallah B, Ali A, Dowaidar M, Settin A.

Saudi J Gastroenterol. 2011 Jul-Aug;17(4):256-60. doi: 10.4103/1319-3767.82580.

14.

Population genetic screening for alpha1-antitrypsin deficiency in a high-prevalence area.

Corda L, Medicina D, La Piana GE, Bertella E, Moretti G, Bianchi L, Pinelli V, Savoldi G, Baiardi P, Facchetti F, Gatta N, Annesi-Maesano I, Balbi B.

Respiration. 2011;82(5):418-25. doi: 10.1159/000325067. Epub 2011 Apr 6.

PMID:
21474916
15.

Outcomes for recipients of liver transplantation for alpha-1-antitrypsin deficiency–related cirrhosis.

Carey EJ, Iyer VN, Nelson DR, Nguyen JH, Krowka MJ.

Liver Transpl. 2013 Dec;19(12):1370-6.

16.

α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts.

Sørheim IC, Bakke P, Gulsvik A, Pillai SG, Johannessen A, Gaarder PI, Campbell EJ, Agustí A, Calverley PM, Donner CF, Make BJ, Rennard SI, Vestbo J, Wouters EF, Paré PD, Levy RD, Coxson HO, Lomas DA, Hersh CP, Silverman EK.

Chest. 2010 Nov;138(5):1125-32. doi: 10.1378/chest.10-0746. Epub 2010 Jul 1.

17.

Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases.

Silverman EK, Mosley JD, Rao DC, Palmer LJ, Province MA, Elston RC, Weiss ST, Campbell EJ.

Hum Hered. 2001;52(4):223-32.

PMID:
11713419
18.
19.

Sanger sequencing solved a cryptic case of severe alpha₁-antitrypsin deficiency.

Zhan SH, Abboud RT, Jung B, Kuchinka B, Ralston D, Casey B, Mattman A.

Clin Biochem. 2012 Apr;45(6):499-501. doi: 10.1016/j.clinbiochem.2012.01.027. Epub 2012 Feb 4.

PMID:
22330941
20.

The prevalence of alpha-1 antitrypsin deficiency in Ireland.

Carroll TP, O'Connor CA, Floyd O, McPartlin J, Kelleher DP, O'Brien G, Dimitrov BD, Morris VB, Taggart CC, McElvaney NG.

Respir Res. 2011 Jul 13;12:91. doi: 10.1186/1465-9921-12-91.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk